Frequently Asked Questions

 

What are the requirements of the EFPIA Disclosure Code?

The EFPIA Disclosure Code is a code of conduct that requires all EFPIA member companies and companies that are members of EFPIA member associations to disclose transfers of value to Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs). Under the Code, EFPIA member companies will have to disclose the names of Healthcare Professionals and Organisations that have received certain transfers of value or payments from them (provided the appropriate consent has been obtained).  They will also have to disclose the total amounts of value transferred by type of activity, which could consist of, for instance, a grant to an HCO, a consultancy fee for speaking, payment for travel, or registration fees to attend a medical education congress. 

 

Please visit the EFPIA Disclosure Code web page for information on the Code and EFPIA member countries, click here.  

 

Note: some EFPIA member countries have deviations from the Disclosure Code, according to local code and/or legal requirements.  Please visit your local code association website for further information.  A link to your local code association is provided in the Methodology section of this website.

 

What is the Astellas methodology for disclosure of transfers of value?

Please click on the Methodology page to see the Astellas methodology for disclosure, according to the EFPIA Disclosure Code and any local code and/or legal requirements.

 

What should I do if I want clarification on the disclosure information published by Astellas?

Please read the information on the Methodology page of this website and/or visit your local code association website for further information.  A link to your local code association is provided in the Methodology section.

 

What should I do if I disagree with the disclosure information published by Astellas?

Please refer to the Enquiries section of this website.

 

How do I change my consent decision?

Please refer to the Enquiries section of this website.

 

How long will Astellas take to respond to my enquiry?

Astellas will aim to respond to your enquiry within 14 working days.  Please visit the Enquiries page for further information on how to submit an enquiry.

 

Can I use this web portal to report an Adverse Event?

No, adverse events should be reported to Astellas Pharma Europe:

by email drugsafety.hu@astellas.com

by facsimile +31 (0)71-545 5208

or contact your local Astellas office (www.astellas.eu/contact/locations/)

 

Why can't I open the Disclosure Report document?

The Disclosure Reports are in pdf format. Please check which version of Adobe Reader you are using. The latest version of Adobe can be downloaded from here.

 

Why am I having trouble viewing or using this web site?

Please check which web browser you are using. This web site supports the following browser versions:


Desktop/Laptop:

Google Chrome 27 and future versions

Microsoft Internet Explorer 9 and future versions

Firefox 26 and future versions

Apple Safari 6 and future versions

Opera 2012 future versions

Mobile:

Apple Safari 6 and future versions

Chrome 27 and future versions

IE 8-11 and future version